0001333277-18-000030.txt : 20180126
0001333277-18-000030.hdr.sgml : 20180126
20180126174141
ACCESSION NUMBER: 0001333277-18-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180124
FILED AS OF DATE: 20180126
DATE AS OF CHANGE: 20180126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Sujal
CENTRAL INDEX KEY: 0001588861
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 18553010
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 7999 GATEWAY BLVD., SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-01-24
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001588861
Shah Sujal
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BOULEVARD
NEWARK
CA
94560
1
1
0
0
Chief Executive Officer
Employee Stock Option (right to buy)
11.69
2018-01-24
4
A
0
150000
0
A
2028-01-23
Common Stock
150000
150000
D
The option vests as to 1/4 of the underlying shares on January 1, 2019, and vests as to 1/48 of the underlying shares monthly thereafter.
Sujal Shah
2018-01-26